Đang chuẩn bị liên kết để tải về tài liệu:
Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Osimertinib is a standard first-line treatment for advanced non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. Although malignant pleural effusion (PE) is a common clinical problem in NSCLC, information about the efficacy of osimertinib in patients with PE is limited, especially regarding its efficacy in EGFR T790M-negative patients with PE remains unclear. |

TÀI LIỆU LIÊN QUAN

Impact of entrepreneurship environmental support factors to university students’ entrepreneurship self-efficacy

Ramification of crowdfunding on Bangladeshi entrepreneur’s self-efficacy

General self-efficacy and posttraumatic stress after a natural disaster: A longitudinal study

Impact of entrepreneurship environmental support factors university students’ entrepreneurship self-efficacy

Comparison of the therapeutic efficacy of microwave ablation and radio-frequency ablation for hepatocellular carcinomas

Effects of active learning methodologies on the students’ emotions, self-efficacy beliefs and learning outcomes in a science distance learning course

Effect of a metacognitive scaffolding on self-efficacy, metacognition, and achievement in e-learning environments

Field assessment of the efficacy of M.B., LIBDV and Winterfield 2512 strain vaccines against infectious bursal disease in chickens

Evaluation of microfilaricidal efficacy of doxycycline, ivermectin and selamectin in dogs naturally infected with Dirofilaria repens

Insecticidal efficacy against shoot and fruit borer, Leucinodes orbonalis Guene
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.